Western blotting analysis using LYN proto-oncogene antibody (Cat#66582). Total cell lysates (30 μg) from various cell lines were loaded and separated by SDS-PAGE. The blot was incubated with LYN proto-oncogene antibody (Cat#66582, 1:1,000) and HRP-conjugated goat anti-mouse secondary antibody (Cat#101, 1:20,000) respectively. Image was developed using NaQ™ ECL Substrate Kit (Cat#716).
Western blotting analysis using LYN proto-oncogene antibody (Cat#66582). LYN proto-oncogene expression in wild-type (WT) and LYN proto-oncogene (LYN) shRNA knockdown (KD) HeLa cells with 20 μg of total cell lysates. Hsp90 α serves as a loading control. The blot was incubated with LYN proto-oncogene antibody (Cat#66582, 1:1,000) and HRP-conjugated goat anti-mouse secondary antibody (Cat#101, 1:20,000) respectively. Image was developed using FeQ™ ECL Substrate Kit (Cat#226).
Immunocytochemical staining of Hela cells with LYN proto-oncogene antibody (Cat#6528, 1:1,000). Nuclei were stained blue with DAPI; LYN proto-oncogene was stained magenta with Alexa Fluor® 647. Images were taken using Leica stellaris 5. Protein abundance based on laser Intensity and smart gain: Medium. Fixative solution: 4% Paraformaldehyde in 1x PBS; Permeabilization solution: 0.5% Triton X-100 in 1x PBS. Scale bar, 20 μm.
Flow cytometric analysis of LYN proto-oncogene expression in HeLa cells using LYN proto-oncogene antibody (Cat#6582, 1:2,000). Fixative solution: 4% Paraformaldehyde in 1x PBS; Permeabilization solution: 100% Methanol, chill on -20℃ before use. Green, isotype control; red, LYN proto-oncogene.
